FIELD: medicine, pharmaceutics.
SUBSTANCE: pharmaceutical oil-in-water emulsion contains mometasone or mometasone furoate, propylene glycol and water. The propylene glycol concentration makes from 20 to approximately 45 wt %. A mass ratio of propylene glycol and water in the oil-in-water emulsion makes from 1:1 to approximately 1:3. A portion of mometasone or mometasone furoate is found insoluble in the emulsion.
EFFECT: composition is characterised by stability and therapeutic effect.
27 cl, 6 dwg, 5 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL FORMULATIONS CONTAINING CORTICOSTEROIDS FOR TOPICAL APPLICATION | 2011 |
|
RU2568598C2 |
STABLE DOSAGE FORM FOR LOCAL APPLICATION CONTAINING VORICONAZOLE | 2009 |
|
RU2472510C2 |
MEDICATION FOR TREATING DERMATOSIS (VERSIONS) | 2013 |
|
RU2548764C2 |
CREAM GEL CONTAINING IVERMECTIN | 2005 |
|
RU2389494C2 |
COMPOSITION FOR TOPICAL USE | 2018 |
|
RU2807884C2 |
COMPOSITIONS FOR PERSONAL CARE, CONTAINING FUNCTIONALISED POLYMERS | 2007 |
|
RU2420262C2 |
COMPOSITION OF LOTION FOR PERSONAL APPLICATION | 2008 |
|
RU2463035C2 |
TOPICAL COMPOSITIONS CONTAINING CORTICOSTEROID | 2016 |
|
RU2690659C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING DERMATOSES THAT CAN BE TREATED BY GLUCOCORTICOSTEROID THERAPY, AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2396081C1 |
LOCAL DELIVERY OF SKIN CARE COMPOSITIONS HAVING LOW PH | 2016 |
|
RU2727807C2 |
Authors
Dates
2014-08-27—Published
2010-05-12—Filed